This is to update and consolidate the extended use date information posted previously to assist with drug shortage (6/15/17 to present).
Similar Posts
17th Annual Sentinel Initiative Public Workshop – 11/06/2025
The U.S. Food and Drug Administration, under a cooperative agreement with the Duke-Margolis Institute for Health Policy, is hosting the 16th Annual Sentinel Initiative Public Workshop on November 6, 2025Q&A on CGMP Requirements
Pharmaceutical Quality/Manufacturing Standards (CGMP)FDA-TRACK: Biosimilar User Fee Act Procedural Response Goals Summary
FDA-TRACK: Biosimilar User Fee Act Procedural Response Goals SummaryUntitled Letters
These letters are supplied by the CDER Freedom of Information Office and only cover Office of Prescription Drug Promotion’s untitled letters. FDA may have redacted or edited some of the letters to remove confidential information.Disseminated Coccidioidomycosis: Developing Drugs for Treatment
Disseminated Coccidioidomycosis: Developing Drugs for TreatmentBioresearch Monitoring Information System (BMIS)
Bioresearch Monitoring Information System (BMIS) background page with download file.